| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
7,010 |
5,990 |
$303K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,154 |
2,675 |
$199K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,761 |
2,261 |
$70K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,238 |
1,017 |
$65K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,112 |
904 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
61 |
58 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
519 |
440 |
$4K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
188 |
145 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
71 |
66 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
12 |
$717.68 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13 |
13 |
$456.30 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
28 |
24 |
$404.06 |
| 99000 |
|
18 |
14 |
$0.00 |
| 99072 |
|
388 |
300 |
$0.00 |